229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.22%
Negative revenue growth while VUZI stands at 3.86%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-19.15%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-27.75%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-27.75%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-25.87%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-25.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-23.40%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.29%
Share reduction while VUZI is at 6.69%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.23%
Reduced diluted shares while VUZI is at 6.69%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
11.26%
Dividend growth of 11.26% while VUZI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-8.34%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-14.14%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
961.28%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
76.57%
Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
41.67%
Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
1056.23%
10Y OCF/share CAGR above 1.5x VUZI's 65.15%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
14.02%
Positive OCF/share growth while VUZI is negative. John Neff might see a comparative advantage in operational cash viability.
60.49%
3Y OCF/share CAGR above 1.5x VUZI's 27.91%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1708.45%
Net income/share CAGR above 1.5x VUZI's 35.28% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
27.05%
Positive 5Y CAGR while VUZI is negative. John Neff might view this as a strong mid-term relative advantage.
33.48%
Positive short-term CAGR while VUZI is negative. John Neff would see a clear advantage in near-term profit trajectory.
1385.00%
10Y equity/share CAGR above 1.5x VUZI's 202.99%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
117.34%
5Y equity/share CAGR at 75-90% of VUZI's 138.50%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
21.19%
Below 50% of VUZI's 153.73%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
33.94%
3Y dividend/share CAGR of 33.94% while VUZI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-4.21%
Firm’s AR is declining while VUZI shows 17.08%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-19.73%
Inventory is declining while VUZI stands at 14.45%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.11%
Asset growth well under 50% of VUZI's 16.19%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-1.73%
We have a declining book value while VUZI shows 8.88%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
6.34%
We have some new debt while VUZI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
1.95%
R&D dropping or stable vs. VUZI's 30.49%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
0.53%
SG&A declining or stable vs. VUZI's 14.22%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.
